| Mobile phone emission modulates inter-hemispheric functional coupling of EEG alpha rhythms in elderly compared to young subjects F Vecchio, C Babiloni, F Ferreri, P Buffo, G Cibelli, G Curcio, ... Clinical Neurophysiology 121 (2), 163-171, 2010 | 101 | 2010 |
| Dose optimization of piperacillin/tazobactam in critically ill children PAJG De Cock, SC van Dijkman, A de Jaeger, J Willems, M Carlier, ... Journal of Antimicrobial Chemotherapy 72 (7), 2002-2011, 2017 | 48 | 2017 |
| Effect of age-related factors on the pharmacokinetics of lamotrigine and potential implications for dose optimisation in epilepsy patients SC van Dijkman, NCB de Jager, WM Rauwé, M Danhof, O Della Pasqua Clinical pharmacokinetics, 1-15, 2017 | 36* | 2017 |
| Pharmacokinetic interactions and dosing rationale for antiepileptic drugs in adults and children SC van Dijkman, WM Rauwé, M Danhof, O Della Pasqua British journal of clinical pharmacology 84 (1), 97-111, 2018 | 35 | 2018 |
| Global functional coupling of resting EEG rhythms is abnormal in mild cognitive impairment and Alzheimer’s disease: a multicenter EEG study C Babiloni, G Frisoni, F Vecchio, R Lizio, M Pievani, C Geroldi, C Fracassi, ... Journal of Psychophysiology 23 (4), 224-234, 2009 | 35 | 2009 |
| Effect of age-related factors on the pharmacokinetics of lamotrigine and potential implications for maintenance dose optimisation in future clinical trials SC van Dijkman, NCB de Jager, WM Rauwé, M Danhof, O Della Pasqua Clinical pharmacokinetics 57 (8), 1039-1053, 2018 | 33 | 2018 |
| Individualized dosing algorithms and therapeutic monitoring for antiepileptic drugs SC van Dijkman, SG Wicha, M Danhof, OE Della Pasqua Clinical Pharmacology & Therapeutics 103 (4), 663-673, 2018 | 26 | 2018 |
| Pharmacotherapy in pediatric epilepsy: from trial and error to rational drug and dose selection–a long way to go SC van Dijkman, R Alvarez-Jimenez, M Danhof, O Della Pasqua Expert opinion on drug metabolism & toxicology 12 (10), 1143-1156, 2016 | 20 | 2016 |
| Futility of current urine salbutamol doping control JAAC Heuberger, SC van Dijkman, AF Cohen British journal of clinical pharmacology 84 (8), 1830-1838, 2018 | 18 | 2018 |
| Dose rationale and pharmacokinetics of dexmedetomidine in mechanically ventilated new-borns: impact of design optimisation SC van Dijkman, PAJG De Cock, K Smets, W Decaluwe, A Smits, ... European journal of clinical pharmacology 75 (10), 1393-1404, 2019 | 17 | 2019 |
| Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects N de Jesus Antunes, SC van Dijkman, VL Lanchote, L Wichert-Ana, ... European Journal of Pharmaceutical Sciences 109, S116-S123, 2017 | 15 | 2017 |
| Biomarkers in epilepsy–A modelling perspective SC van Dijkman, RA Voskuyl, EC de Lange European Journal of Pharmaceutical Sciences 109, S47-S52, 2017 | 10 | 2017 |
| Cardiac sodium channel inhibition by lamotrigine: In vitro characterization and clinical implications L Ingleby‐Talecki, SC van Dijkman, SP Oosterholt, O Della Pasqua, ... Clinical and Translational Science 15 (8), 1978-1989, 2022 | 9 | 2022 |
| Correction to: effect of age-related factors on the pharmacokinetics of lamotrigine and potential implications for maintenance dose optimisation in future clinical trials SC van Dijkman, NCB de Jager, WM Rauwé, M Danhof, O Della Pasqua Clinical Pharmacokinetics 57 (8), 1055-1056, 2018 | 2 | 2018 |
| Correction to: effect of age-related factors on the pharmacokinetics of lamotrigine and potential implications for maintenance dose optimisation in future clinical trials SC van Dijkman, NCB de Jager, WM Rauwé, M Danhof, O Della Pasqua Clinical Pharmacokinetics 57 (8), 1055-1056, 2018 | 2 | 2018 |
| Personalised pharmacotherapy in paediatric epilepsy: the path to rational drug and dose selection SC van Dijkman Leiden University, 2017 | 1 | 2017 |
| Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials SC van Dijkman, A Yorgancıoğlu, I Pavord, G Brusselle, PM Pitrez, ... Advances in Therapy 41 (3), 1201-1225, 2024 | | 2024 |
| Understanding the effect of clinical baseline characteristics on SABA reliever use in patients with moderate-severe asthma I Pavord, D Singh, G Garcia, S Van Dijkman, S Oosterholt, C Teli, A Pg, ... ALLERGY 78, 158-159, 2023 | | 2023 |
| Impact of treatable traits and treatment choices on reliever/rescue medication use D Singh, I Pavord, G Garcia, S Van Dijkman, S Oosterholt, J Duong, C Teli, ... RESPIROLOGY 28, 99-100, 2023 | | 2023 |
| MODELING OF SHORT-ACTING BETA AGONIST (SABA) USE: EFFECT OF SYMPTOM CONTROL IN PATIENTS WITH MODERATE-SEVERE ASTHMA REQUIRING RESCUE MEDICATION P PITREZ, GUYG BRUSSELLE, A YORGANCIOĞLU, IAN D PAVORD, ... Chest 162 (4), A2674-A2676, 2022 | | 2022 |
